Dose–response associations between metabolic indexes and the risk of comorbid type 2 diabetes mellitus among rheumatoid arthritis patients from Northern China: a case–control study

Abstract

ObjectiveTo investigate whether there were any differences in the patterns of metabolic abnormalities between patients with rheumatoid arthritis (RA) with comorbid type 2 diabetes mellitus (T2DM) and other populations, and to plot the dose–response relationships between metabolic indexes and the risk of comorbid T2DM among patients with RA.Design and settingThis is a retrospective case–control study using electronic medical records (EMRs). Patients with RA and/or T2DM or controls who were admitted to the First Affiliated Hospital of China Medical University between April 2008 and December 2016 were retrospectively recruited through the EMR system. After age-matching and sex-matching, 261 controls, 274 patients with T2DM, 276 patients with RA and 151 patients with RA+T2DM were eventually recruited.ResultsPatients with RA+T2DM exhibited higher levels of systolic blood pressure (SBP), fasting plasma glucose (FPG) and triglyceride (TG) than the RA only patients. Moreover, the proportions of impaired fasting glucose (IFG), and total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C) dyslipidaemia in the RA+T2DM group were higher than those in the RA alone group (for IFG: 28.48% vs 18.84%, p=0.02; for TC: 25.17% vs 15.22%, p=0.01; for LDL-C: 25.83% vs 17.03%; p=0.03). Rheumatoid factor (RF) positivity and IFG were independent risk indicators for comorbid T2DM among patients with RA (for RF positivity: OR=0.45; 95% CI: 0.29 to 0.69; p<0.001; for IFG: OR=1.70; 95% CI: 1.04 to 2.76; p=0.03).ConclusionLinear dose–response associations between SBP, TC, TG and the risk of comorbid T2DM among patients with RA were observed, whereas a non-linear dose–response association between FPG and the risk of comorbid T2DM was found. Patients with RA+T2DM were more likely to exhibit metabolic abnormalities than RA only patients. Patients with RA+T2DM with metabolic abnormalities deserve more attention from rheumatologists and endocrinologists.

Predictive value of echocardiographic left atrial size for incident stoke and stroke cause mortality: a population-based study

“…Importantly, using the drawn dose–response curves, we could calculate the risks of developing stroke and subsequent mortality at any specific LAD or LAD/BSA values, which would facilitate risk assessment and individualised management strategies. 30 Above findings implied that close monitoring of echocardiographic LAD increment might add predictive information in the evaluation of stroke and its mortality, which needed to be validated through replication in other populations. However, Mosquera et al found that LAD/BSA raised the risk of stroke in 50.7% per 1 cm/m 2 increment in bivariate analysis, which association disappeared after multivariate regression.…”

Incremental significance and sex discrepancies of neck circumference on the odds of ischaemic stroke: a multistage, population-based, cross-sectional study from Northeast China

“…macro provided by Desquilbet and Mariotti 23 and had been previously applied in one of my previous articles. 24 Both the overall associations and non-linear associations between NC or NHR and odds of IS were examined. If the test for the overall association between NC or NHR and the odds of IS was statistically significant, NC or NHR was significantly associated with IS, regardless of the shape of the associations.…”